Patents by Inventor Yae Jin Yoon

Yae Jin Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11945779
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer metastasis, a health functional food, and a method for preventing or treating cancer metastasis using the same, containing a novel compound for inhibiting migration and invasion of cancer cells or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: April 2, 2024
    Assignee: VSPHARMTECH
    Inventors: Byoung-Mog Kwon, Dong Cho Han, Yae Jin Yoon, Yu Jin Lee, Jiyoun Choi, Sangku Lee
  • Publication number: 20210246105
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer metastasis, a health functional food, and a method for preventing or treating cancer metastasis using the same, containing a novel compound for inhibiting migration and invasion of cancer cells or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: May 2, 2019
    Publication date: August 12, 2021
    Inventors: Byoung-Mog KWON, Dong Cho HAN, Yae Jin YOON, Yu Jin LEE, Jiyoun CHOI, Sangku LEE
  • Patent number: 10675244
    Abstract: The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: June 9, 2020
    Assignee: MDIMUNE INC.
    Inventors: Yong Song Gho, Yoon Keun Kim, Su Chul Jang, Oh Youn Kim, Dong-Sic Choi, Yae Jin Yoon
  • Publication number: 20180296483
    Abstract: The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.
    Type: Application
    Filed: April 23, 2018
    Publication date: October 18, 2018
    Applicant: MDIMUNE INC.
    Inventors: Yong Song Gho, Yoon Keun Kim, Su Chul Jang, Oh Youn KIM, Dong-Sic CHOI, Yae Jin YOON
  • Publication number: 20140044647
    Abstract: The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.
    Type: Application
    Filed: October 18, 2013
    Publication date: February 13, 2014
    Applicant: Aeon Medix Inc.
    Inventors: Yong Song GHO, Yoon Keun Kim, Su Chul Jang, Oh Youn Kim, Dong-Sic Choi, Yae Jin Yoon
  • Publication number: 20120177574
    Abstract: The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.
    Type: Application
    Filed: July 1, 2010
    Publication date: July 12, 2012
    Applicant: AEON MEDIX INC.
    Inventors: Yong Song Gho, Yoon Keun Kim, Su Chul Jang, Oh Youn Kim, Dong-Sic Choi, Yae Jin Yoon